Back to results
US 2019/0314444 A1Published application
Etbr antagonist compounds, compositions, and uses
AssigneeENB Therapeutics, Inc.
InventorSumayah JAMAL
Life of this patent
Estimating the term…
Abstract
Disclosed herein are ETBR antagonist compounds, pharmaceutical compositions thereof, methods for treating cancers, and methods of forming tertiary lymphoid organs.
Claims21
-70. (canceled)
A method of forming a tertiary lymphoid organ (TLO) in a subject in need thereof, comprising administering to the subject an effective amount of a pharmaceutical composition comprising an ETBR antagonist and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.